From: Association of p21 SNPs and risk of cervical cancer among Chinese women
 | Patients | controls |  |  |
---|---|---|---|---|
 | (n=393) | (n=434) |  |  |
haplotype | No. (%) | No. (%) | OR (95% CI) | P*a |
ht1-AGT | Â | Â | Â | Â |
ht1/ht1 | 67 (17.0) | 87 (20.0) | 0.643 (0.434-0.954) | 0.028 |
ht1/- | 166 (42.2) | 215(49.5) | 0.636 (0.467-0.865) | 0.004 |
−/− | 160(40.7) | 132(30.4) | reference |  |
ht2- CCC | Â | Â | Â | Â |
ht2/ht2 | 26 (6.6) | 41 (9.4) | 0.628 (0.368-1.072) | 0.088 |
ht2/- | 183 (46.6) | 210 (48.4) | 0.865 (0.650-1.151) | 0.321 |
−/− | 184 (46.8) | 183 (42.2) | reference |  |
ht3-CGC | Â | Â | Â | Â |
ht3/ht3 | 51 (13.0) | 21 (4.8) | 3.047 (1.788-5.192) | 0.000 |
ht3/- | 59 (15.0) | 56 (12.9) | 1.322 (0.888-1.970) | 0.169 |
−/− | 283 (72.0) | 357 (82.3) | reference |  |
ht4- CGT | Â | Â | Â | Â |
ht4/ht4 | 3(0.8) | 1(0.2) | 3.054 (0.311-29.936) | 0.338 |
ht4/- | 50 (12.7) | 32 (7.4) | 1.846 (1.156-2.945) | 0.010 |
−/− | 340 (86.5) | 401 (92.4) | reference |  |